尊龙凯时人生就是赢(中国)官方网站尊龙凯时

尊龙凯时药业
CDMO
API & Intermediate CDMO Finished Dosage Form Aesthetic & Care Ingredients
About CDMO
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
Top 5
player in small molecular field in China
Apeloa CDMO is the contract manufacturing focused business of Apeloa, with strategically developed its business towards becoming one of the world's premier contract service organizations. Supported by a global network of manufacturing, development, and analytical facilities, Apeloa CDMO provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials (RSMs). The company's commitment to leading-edge science, best-in-class customer service, and regulatory compliance drives its success in the CDMO industry.
420+
customers globally
3 global R&D centers: ● Boston, USA --- Function in Q2 2024; 16,000 sq ft; 40+ chemists in two years; Tech Development Platform/Lead optimization/Screening/Tox Batch preparation ● Shanghai, China --- 68,000 sq ft; 300+ chemists; Screening/Process development/optimization/CMC ● Hengdian, China --- 88,000 sq ft; 250+ chemists; Process optimization/Tech transfer/CMC
One-Stop Service
Apeloa CDMO offers comprehensive services covering the entire lifecycle, from drug discovery to commercial production. Includes Discovery Service, Chemistry Excellence, Chemical Process R&D, Custom and Commercial Production.
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
Technology Platforms
Apeloa CDMO has built cutting-edge expertise and capabilities across a wide range of technical platforms to meet the market’s expectations. Our state-of-the-art facilities and expert teams ensure efficient and innovative solutions that advance customer molecules to market.
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
Manufacturing Capacity
8 manufacturing sites with cGMP, ISO9001, ISO14001, OSHAS18001 and IPMS certifications, 4 sites passed US FDA, 3 sites passed PMDA, 2 sites passed EDQM
Total chemical synthesis capacity: 11,000 m³ (Stainless Steel/Glass/Hastelloy/Titanium alloy/Teflon)
Total bio-production capacity: 6,570 m³ (Stainless Steel)
3 new multi-functional API workshops for parallel productions at varied scales (658 m³ in total)
High Potency API Facility for clinical & commercial scale (75 m³ in total)
尊龙凯时